Gibbs Wealth Management’s LeMaitre Vascular LMAT Stock Holding History

Gibbs Wealth Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.13M	Buy	10,329 +3,674	+55%	+$350K	0.15%	134
2025 Q4	$566K	Sell	6,655 -1,284	-16%	-$111K	0.14%	175
2025 Q3	$695K	Sell	7,939 -1,785	-18%	-$159K	0.16%	154
2025 Q2	$808K	Buy	9,724 +1,590	+20%	+$133K	0.16%	158
2025 Q1	$682K	Buy	8,134 +15	+0.2%	+$1.4K	0.16%	145
2024 Q4	$748K	Buy	8,119 +1,360	+20%	+$131K	0.2%	108
2024 Q3	$628K	Buy	6,759 +2,031	+43%	+$176K	0.2%	109
2024 Q2	$389K	Buy	4,728 +1,499	+46%	+$110K	0.16%	154
2024 Q1	$214K	Buy	+3,229	New	+$199K	0.12%	181

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Gibbs Wealth Management's LMAT Position: Q1 2026 in Review

Gibbs Wealth Management increased its LeMaitre Vascular (LMAT) stake by 55% in Q1 2026, buying an estimated $350K and bringing the position to 10,329 shares worth $1.13M. The position accounts for 0.15% of the portfolio, ranked #134.

Gibbs Wealth Management first reported a position in LMAT in Q1 2024 and has held it in 9 quarters since. 340 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Gibbs Wealth Management held 10,329 shares of LeMaitre Vascular worth $1.13M as of Q1 2026.
Gibbs Wealth Management bought 3,674 LeMaitre Vascular shares in Q1 2026, an estimated $350K.
LeMaitre Vascular made up 0.15% of Gibbs Wealth Management's portfolio in Q1 2026, its #134 holding.
Gibbs Wealth Management first reported a position in LeMaitre Vascular in Q1 2024 and has held it in 9 quarters since.
340 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.